UC San Diego Health offers new immunotherapy treatment for multiple myeloma following FDA approval

By | June 4, 2021
Following the Food and Drug Administration’s approval, UC San Diego Health is the first designated medical center in San Diego certified to offer a new immunotherapy treatment of multiple myeloma outside of a clinical trial.